In a world where certain health conditions dominate headlines and funding priorities, sickle cell disease — a genetic blood ...

Bluebird Bio and Xcellbio have entered into an agreement to support the commercialization of Lyfgenia (lovotibeglogene autotemcel), Bluebird’s gene therapy for sickle cell disease, incorporating ...

In New York, a 21-year-old man has been cured of sickle cell anemia. In a groundbreaking treatment, doctors used his own bone marrow in IV transfusions to create normal red blood cells - making him ...

As I look back on my two-year journey as a sickle cell disease columnist for Bionews ... I can confidently say that it’s been a rewarding journey filled with learning and self-discovery. When I ...

What we know: Sebastien Beauzile, 21, was born with sickle cell anemia, a hereditary blood disorder that can cause severe pain, tissue damage, and serious complications. But now, he has become ...